The rise of Sildenafil initially drove a boom for the drug industry, nevertheless recent developments present a murky picture for investors. Generic competitors are reducing earnings, and ongoing litigation add https://elainezhco174329.canariblogs.com/the-blue-pill-and-the-pharmaceutical-industry-a-risky-play-56103814